The novel treatment of the medication represents a significant development in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide176093.blogsidea.com/48912330/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment